Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy

BACKGROUND: The aim of this study was to evaluate the safety and survival outcomes of anti-programmed cell death (PD)-1/programmed cell death-ligand 1 (PD-L1) monotherapy in patients with advanced non-small cell lung cancer (NSCLC) and different hepatitis B virus (HBV) infection status. METHODS: Pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xuanye, Tian, Dan, Chen, Yue, Chen, Chen, He, Li-Na, Zhou, Yixin, Li, Haifeng, Lin, Zuan, Chen, Tao, Wang, Yuhong, Russo, Alessandro, Nadal, Ernest, Passiglia, Francesco, Soo, Ross Andrew, Watanabe, Satoshi, Moran, Teresa, Oh, In-Jae, Fu, Sha, Hong, Shaodong, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350074/
https://www.ncbi.nlm.nih.gov/pubmed/34430357
http://dx.doi.org/10.21037/tlcr-21-455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350074/
https://www.ncbi.nlm.nih.gov/pubmed/34430357
http://dx.doi.org/10.21037/tlcr-21-455

Ejemplares similares